Investor Webinar to be held Monday, August 10th at 10 am Eastern Time
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
TORONTO, Aug. 07, 2020 (GLOBE NEWSWIRE) -- Social-impact investment company QuestCap Inc. (CSE:QSC; FRA:34C1) is pleased to host a corporate webinar to provide updates and developments from investment partners.
QuestCap’s recent investments include:
- Glenco Medical Corp. is a medical treatment company that specializes in extended clinical care, home treatment and innovative performance technologies using wearable, unrestricted and individual therapies to accelerate orthopaedic injury healing and training recovery. Glenco Medical develops and organizes data driven COVID-19 screening protocols and testing procedures. As virus testing is crucial for recovery, these protocols are designed to provide a safe return for business operations, manufacturing, hydropower plants, service sectors, sports, technology industries etc. using up to date local public health recommendations and guidelines.
- Amino Therapeutics is currently focused on developing biologic therapeutics for COVID-19. Amino’s research targets small molecule drug candidates and targeted drug delivery systems to transport biologics into the cytosol.
- Spectral Analytics received Institutional Review Board (IRB) approval for the clinical study and is the Principal Investigator for the Phase 1 study. Spectral is testing the efficacy of the combination of two FDA approved drugs to treat COVID 19.
“We’ve been very focused on putting our capital to work in projects that show promise in mitigating the spread of the virus while indicating an opportunity to deliver strong financial results,” said Doug Sommerville, CEO of QuestCap. “We’ve leveraged the specialized knowledge of our Global Advisory Team to help identify, connect with, and guide our investments into these high-potential projects as well as new opportunities post COVID19. We’re very pleased with the progress we are seeing.”
| QuestCap Corporate Update Webinar QuestCap is hosting a Corporate Update webinar on Monday, August 10 at 10 am Eastern time that will give the Company’s investment partners the opportunity to provide an update on their work. Select representatives will make short presentations on their progress. Registration Link https://us02web.zoom.us/webinar/register/WN_nZtjhxAvSbej0hB06tbKRQ |
About QuestCap Inc.
QuestCap Inc. (CSE:QSC; FRA:34C1) is a social-impact investment company. It seeks, secures and funds recognized sciences, technologies, and solutions that impact our global community today.
The QuestCap executive team is complemented by a panel of global advisors that provide expertise across industries and geographies. This panel includes prominent immunologist Dr. Lawrence Steinman and Dr. Glenn Copeland, who has 45 years of experience in orthopedic treatment, foot and ankle care, and sports medicine.
QuestCap provides financing for a diverse range of entities in exchange for pre-determined royalties or distributions, or acquires all or part of one or more businesses, portfolios or other assets.
For additional information, please contact:
Doug Sommerville, CEO
Doug.Sommerville@Questcapinc.com
416-301-5418
For US media enquires please contact:
Veronica Welch
veronica@vewprmedia.com
+1-508-643-8000
Cautionary Note Regarding Forward-looking Information
This press release contains "forward-looking information" within the meaning of applicable Canadian securities legislation. Forward-looking information includes, but is not limited to, statements with respect to the use of the corporate update; the pursuit by QuestCap of investment opportunities; and the merits or potential returns of any such investments. Generally, forward-looking information can be identified by the use of forward-looking terminology such as "plans", "expects" or "does not expect", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or state that certain actions, events or results "may", "could", "would", "might" or "will be taken", "occur" or "be achieved". Forward-looking information is subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company, as the case may be, to be materially different from those expressed or implied by such forward-looking information. Although the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking information. The Company does not undertake to update any forward-looking information, except in accordance with applicable securities laws.
NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATION SERVICES PROVIDER HAS REVIEWED OR ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.